loadpatents
Patent applications and USPTO patent grants for Rau; Doris.The latest application filed is for "binding molecules for bcma and cd3".
Patent | Date |
---|---|
Binding Molecules For Bcma And Cd3 App 20220251243 - Kufer; Peter ;   et al. | 2022-08-11 |
Method For Treating Glioblastoma Or Glioma With Anitbody Constructs Egfrviii And Cd3 App 20220064308 - Raum; Tobias ;   et al. | 2022-03-03 |
Binding Molecules For Bcma And Cd3 App 20220064336 - Kufer; Peter ;   et al. | 2022-03-03 |
Cross-species-specific Single Domain Bispecific Single Chain Antibody App 20220041736 - Kufer; Peter ;   et al. | 2022-02-10 |
Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 Grant 11,155,629 - Raum , et al. October 26, 2 | 2021-10-26 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20210277143 - KUFER; Peter ;   et al. | 2021-09-09 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20210269550 - KUFER; Peter ;   et al. | 2021-09-02 |
Bispecific antibody constructs for CDH3 and CD3 Grant 11,028,171 - Weiss , et al. June 8, 2 | 2021-06-08 |
Cross-species-specific single domain bispecific single chain antibody Grant 10,981,998 - Kufer , et al. April 20, 2 | 2021-04-20 |
Cross-species-specific Pscaxcd3, Cd19xcd3, C-metxcd3, Endosialinxcd3, Epcamxcd3, Igf-1rxcd3 Or Fapalphaxcd3 Bispecific Single Chain Antibody App 20200362039 - Kufer; Peter ;   et al. | 2020-11-19 |
Binding molecules for BCMA and CD3 Grant 10,766,969 - Kufer , et al. Sep | 2020-09-08 |
Binding molecules for BCMA and CD3 Grant 10,752,694 - Kufer , et al. A | 2020-08-25 |
Antibody Constructs For Egfrviii And Cd3 App 20200140558 - Raum; Tobias ;   et al. | 2020-05-07 |
Cross-species-specific Bispecific Binders App 20200095319 - Kufer; Peter ;   et al. | 2020-03-26 |
Antibody Constructs For Cdh19 And Cd3 App 20200071405 - Xiao; Shouhua ;   et al. | 2020-03-05 |
Antibody constructs for EGFRVIII and CD3 Grant 10,519,241 - Raum , et al. Dec | 2019-12-31 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20190169310 - Kufer; Peter ;   et al. | 2019-06-06 |
Compositions Comprising Cross-species-specific Antibodies And Uses Thereof App 20190070290 - Kischel; Roman ;   et al. | 2019-03-07 |
Antibody Constructs For Cdh19 And Cd3 App 20190016805 - Xiao; Shouhua ;   et al. | 2019-01-17 |
Antibody constructs for CDH19 and CD3 Grant 10,059,766 - Xiao , et al. August 28, 2 | 2018-08-28 |
Pharmaceutical compositions with resistance to soluble CEA Grant 9,982,063 - Lutterbuse , et al. May 29, 2 | 2018-05-29 |
Bispecific Antibody Constructs For Cdh3 And Cd3 App 20180142021 - Weiss; Bertram ;   et al. | 2018-05-24 |
Pharmaceutical compositions with resistance to soluble CEA Grant 9,695,250 - Lutterbuse , et al. July 4, 2 | 2017-07-04 |
Pharmaceutical Compositions With Resistance To Soluble Cea App 20170137538 - Lutterbuse; Ralf ;   et al. | 2017-05-18 |
Binding molecules for BCMA and CD3 Grant 9,598,500 - Kufer , et al. March 21, 2 | 2017-03-21 |
Cross-species-specific PSMAxCD3 bispecific single chain antibody Grant 9,587,036 - Kufer , et al. March 7, 2 | 2017-03-07 |
Antibody Constructs For Egfrviii And Cd3 App 20170029512 - Raum; Tobias ;   et al. | 2017-02-02 |
Antibody Constructs For Msln And Cd3 App 20170029502 - Raum; Tobias ;   et al. | 2017-02-02 |
Binding Molecules For Bcma And Cd3 App 20160176973 - Kufer; Peter ;   et al. | 2016-06-23 |
Cross-species-specific Bispecific Binders App 20160152707 - Kufer; Peter ;   et al. | 2016-06-02 |
Binding molecules for BCMA and CD3 Grant 9,340,621 - Kufer , et al. May 17, 2 | 2016-05-17 |
Antibody Constructs For Cdh19 And Cd3 App 20150368343 - Xiao; Shouhua ;   et al. | 2015-12-24 |
Binding molecules for BCMA and CD3 Grant 9,150,664 - Kufer , et al. October 6, 2 | 2015-10-06 |
Binding Molecules For Bcma And Cd3 App 20150023967 - Kufer; Peter ;   et al. | 2015-01-22 |
Pharmaceutical antibody compositions with resistance to soluble CEA Grant 8,901,278 - Rau , et al. December 2, 2 | 2014-12-02 |
Binding Molecules For Bcma And Cd3 App 20140348837 - Kufer; Peter ;   et al. | 2014-11-27 |
Antibody Constructs for CDH19 and CD3 App 20140322218 - Xiao; Shouhua ;   et al. | 2014-10-30 |
Pharmaceutical Compositions With Resistance To Soluble Cea App 20130273050 - LUTTERBUSE; Ralf ;   et al. | 2013-10-17 |
Binding Molecules For Bcma And Cd3 App 20130156769 - Kufer; Peter ;   et al. | 2013-06-20 |
Binding Molecules For Bcma And Cd3 App 20130156770 - Kufer; Peter ;   et al. | 2013-06-20 |
Compositions Comprising Cross-species-specific Antibodies And Uses Thereof App 20130129729 - KISCHEL; Roman ;   et al. | 2013-05-23 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20130129730 - Kufer; Peter ;   et al. | 2013-05-23 |
Pharmaceutical compositions with resistance to soluble CEA Grant 8,394,926 - Lutterbuse , et al. March 12, 2 | 2013-03-12 |
Cross-species-specific Bispecific Binders App 20120244162 - KUFER; Peter ;   et al. | 2012-09-27 |
Composition comprising cross-species-specific antibodies and uses thereof Grant 8,236,308 - Kischel , et al. August 7, 2 | 2012-08-07 |
Pharmaceutical Antibody Compositions With Resistance To Soluble Cea App 20120121600 - RAU; Doris ;   et al. | 2012-05-17 |
CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20120034228 - Kufer; Peter ;   et al. | 2012-02-09 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20110293619 - Kufer; Peter ;   et al. | 2011-12-01 |
Cross-species-specific Bispecific Binders App 20100183615 - Kufer; Peter ;   et al. | 2010-07-22 |
Cross-species-specific Binding Domain App 20100150918 - Kufer; Peter ;   et al. | 2010-06-17 |
Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof App 20090252683 - Kischel; Roman ;   et al. | 2009-10-08 |
Pharmaceutical Compositions With Resistance To Soluble Cea App 20090226432 - Lutterbuse; Ralf ;   et al. | 2009-09-10 |
Pharmaceutical Antibody Compositions With Resistance To Soluble Cea App 20090226444 - Rau; Doris ;   et al. | 2009-09-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.